Search this Site

Brand Name(s): Visken; Betapindol; Calvisken;

Decreten; Durapindol
CAS nº: 13523-86-9
(PIN doh lol)

About Pindolol

This new site is dedicated exclusively to pindolol.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about pindolol on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.

This unique site will also offer you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total pindolol experience! 

Why is this medication prescribed?

Pindolol is in a group of drugs called beta-blockers, and is used to treat hypertension (high blood pressure).

This medication works by relaxing the blood vessels so the heart doesn't have to pump as hard. It is effective alone or in combination with other high blood pressure medications, particularly with a thiazide-type diuretic.

This medication may be also used to treat angina pectoris. The use of pindolol in the treatment of instable angina may be less effective compared to beta blockers without ISA (Intrinsic Sympathomimetic Activity).

See more Product Info

Latest News

Hypertension: 'The Silent Killer'

Keeping blood pressure under control is vital to your health

[more]

Blood pressure therapy may dull elderly`s thinking

Islamabad: Lowering blood pressure too aggressively may harm an older patient’s ability to think...

[more]

Beta-blockers 'increase diabetes risk by 50 per cent'

Patients taking beta-blockers for their blood pressure have a 50 per cent higher risk of developing...

[more]

Researchers' data from the United States, Argentina and France advance depression research

Data on depression are outlined in reports from the United States, Argentina and France. Study 1:...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.